NCT02589353View on ClinicalTrials.gov

Human Oral Detection of Glucose Olygomers

PHASE4CompletedINTERVENTIONAL

Enrollment

157

Participants

Timeline

Start Date

April 21, 2017

Primary Completion Date

December 16, 2022

Study Completion Date

February 16, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Acarbose

Acarbose solution will be swabbed on the tip of the tongue to inhibit salivary alpha amylase activity; each swab will contain \~484 microgram acarbose; total maximum exposure of each subject to acarbose will be \~14-30 mg each session (1-20 sessions)

Trial Locations (1)

97331

Department of Food Science and Technology, Corvallis

All Listed Sponsors

lead

Oregon State University

OTHER

NCT02589353 - Human Oral Detection of Glucose Olygomers | Biotech Hunter | Biotech Hunter